Tracon Pharmaceuticals (TCON) PT Raised to $6 at Jefferies
Tweet
Share
E-mailGet Alerts TCON Hot Sheet
Price: $1.43 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Jefferies analyst Maury Raycroft raised the price target on Tracon Pharmaceuticals (NASDAQ: TCON) to $6.00 (from $5.50) while maintaining a Buy rating.
You May Also Be Interested In
- CIBC Upgrades National Bank of Canada (NA:CN) (NTIOF) to Outperformer
- CrowdStrike (CRWD) PT Adjusted $250 at Cantor Fitzgerald Post Stock Split
- Royal Bank of Canada (RY:CN) (RY) PT Raised to Cdn$311 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
